Women have been using men’s Viagra for years, claiming it improves blood flow to the vagina and even increases sex drive. A 2004 study supported these positive results. But the Food and Drug Administration has long refused to get on board, neither approving men’s Viagra for women’s use, nor endorsing medications developed especially for women. This all may be changing, though, as the FDA is poised to sign off on a drug developed by Sprout Pharmaceuticals, whose technical name is 'flibanserin. Despite reportedly causing such side effects as dizziness and nausea, this new drug addresses hypoactive sexual desire disorder, which causes low sex drive in women. Would you try a drug designed to amp up your sex drive? Do you think the FDA’s previous decisions have revealed a gender bias? Sound off in the comments.